The Board of Directors has established an Executive Committee in accordance with the provisions of Article 524bis of the Belgian Company Code. The Executive Committee is composed of several persons, which may or may not be directors. The CEO acts as chairman of the Executive Committee.

The members of the Executive Committee are:

• Gerardus van Jeveren — Chairman and CEO Fagron
• Jan Peeters — CFO
• Frank Verbakel — Group Controller
• Mario Huyghe — CEO Arseus Dental en Arseus Medical
• Dirk Van Lerberghe — CEO Corilus

Gerardus van Jeveren (1960): Chief Executive Officer

Gerardus van Jeveren is the Chief Executive Officer of Arseus. Mr. van Jeveren was the founder and main shareholder of Fagron Farmaceuticals BV, which was acquired by Omega Pharma in 2000. Before founding Fagron he held various sales and marketing positions, including commercial manager at Pharbita Generics, a subsidiary of Medicopharma NV. After Omega Pharma’s acquisition of Fagron, Mr. van Jeveren was appointed country manager of Omega Pharma, responsible for the Netherlands and Germany. In 2003 he was appointed Business Unit Manager of Fagron, responsible for the Netherlands, Belgium, Germany and Spain, and in 2006 he was appointed CEO of Arseus. He is a graduate of the teacher training college Zuid-West-Nederland in Delft.

Jan Peeters (1966): Chief Financial Officer

Jan Peeters is the Chief Financial Officer of Arseus. Mr. Peeters was appointed Omega Pharma’s Chief Financial Officer in 1993, after three years as a business analyst at Exxon Chemical International. Mr. Peeters was Omega Pharma’s CFO for eight years, a period that included the firm’s successful IPO. In 2001 Mr. Peeters was appointed Deputy Chief Executive Officer of Omega Pharma, a position he held until 7 November 2006. In 2005 he was appointed Business Unit Manager of Omega’s dental division (now Arseus Dental) and given overall responsibility for Arseus’s split from Omega Pharma. In 2006 he was appointed CFO of Arseus. Mr. Peeters holds a Master’s degree in applied economics from Antwerp University and a postgraduate degree in management from Vlerick Management School.

Frank Verbakel (1960): Group Financial Controller

Frank Verbakel is the group financial controller of Arseus. Between 1983 and 1996 Mr. Verbakel held various financial positions at the Pharmaceutical division of Akzo Nobel. In 1997 he was appointed Controller of the Chefaro Division of Akzo Nobel, which was acquired by Omega Pharma in 2000. In 2004 Mr. Verbakel was appointed Business Unit Controller of Fagron and in 2007 he was appointed Group Financial Controller and Member of the Executive Committee of Arseus. Mr. Verbakel studied business economics at the Fontys College in Eindhoven.

Mario Huyghe (1963, Belgium)

Mario Huyghe has been responsible for the Arseus Medical division since January 1, 2009. Mario began his career at the Belgian distribution group Meda (now Acertys). The past nine years, Mario has held a number of leading positions within General Electric Healthcare, where he was responsible for the “Life Support Anesthesia-Carestation” division from 2005 to 2008. Mario graduated as an engineer from the Catholic University of Leuven and obtained an MBA from the Vlerick Leuven Ghent Management School.

Dirk Van Lerberghe (1963, Belgium)

Dirk Van Lerberghe has been responsible for the Corilus division since May 25, 2009. Dirk started his career at Sycron in Sales and climbed up the ranks, eventually becoming General Director for Belgium, the Netherlands and France. Sycron was later absorbed by Real Software, where Dirk Van Lerberghe was a member of the Executive Committee. Dirk is highly experienced in developing international customer networks. He also gained extensive experience in the medical sector through the creation and development of an application for automating surgical operating departments. Dirk studied at the EHSAL in Brussels.